2023
Impact of COVID-19 on the gastrointestinal surgical oncology patient population
Bakkila B, Marks V, Kerekes D, Kunstman J, Salem R, Billingsley K, Ahuja N, Laurans M, Olino K, Khan S. Impact of COVID-19 on the gastrointestinal surgical oncology patient population. Heliyon 2023, 9: e18459. PMID: 37534012, PMCID: PMC10391949, DOI: 10.1016/j.heliyon.2023.e18459.Peer-Reviewed Original ResearchGI cancer surgeryPreoperative chemotherapyCancer surgerySurgical careCOVID-19 pandemicCOVID-19Tertiary referral centerOncology patient populationFirst COVID-19 waveGI cancer casesCOVID-19 burdenHigh COVID-19 burdenEmergency surgeryReferral centerCOVID-19 waveOncology visitsGastrointestinal cancerGI cancersPatient populationStudy criteriaCancer careTreatment characteristicsCancer casesCase volumePatients
2020
Treatment Selection and Survival Outcomes in Locally Advanced Proximal Gastric Cancer: A National Cancer Data Base Analysis
Tang S, Liu F, Li Y, Zhao L, Wang X, Khan SA, Chen Y, Zhang Y. Treatment Selection and Survival Outcomes in Locally Advanced Proximal Gastric Cancer: A National Cancer Data Base Analysis. Frontiers In Oncology 2020, 10: 537051. PMID: 33102212, PMCID: PMC7546198, DOI: 10.3389/fonc.2020.537051.Peer-Reviewed Original ResearchBetter long-term outcomesProximal gastrectomyTotal gastrectomyLong-term outcomesPreoperative chemotherapyAdvanced proximal gastric cancer patientsNational Cancer Data Base analysisAdvanced proximal gastric cancerProximal gastric cancer patientsNational Cancer Data BaseCox proportional hazards modelPostoperative chemoradiation therapyProximal gastric cancerUnderwent proximal gastrectomyUnderwent total gastrectomyImproved overall survivalProximal gastric adenocarcinomaGastric cancer patientsProportional hazards modelLong-term survivalEligible patientsPostoperative chemotherapyAdjuvant therapyChemoradiation therapyMultimodality treatment